Activities of three quinolones, alone and in combination with extended- spectrum cephalosporins or gentamicin, against stenotrophomonas maltophilia

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 8, 1998, Pages 2002-2005

  Visalli, Melissa A ^a   Jacobs, Michael R ^b   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOPERAZONE; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA;

EID: 0031901893     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.8.2002     Document Type: Article

References (18)

1. Bajaksouzian, S., M. A. Visalli, M. R. Jacobs, and P. C. Appelbaum. 1997. Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies. Antimicrob. Agents Chemother. 41:1073-1076.
2. Bush, K. 1989. Classification of β-lactamases: groups 2c, 2d, 2e, 3, and 4. Antimicrob. Agents Chemother. 33:271-276.
3. Cullmann, W. 1991. Antibiotic susceptibility and outer membrane proteins of clinical Xanthomonas maltophilia isolates. Chemotherapy (Basel) 37:246-250.
4. Eliopoulos, G. M., and R. C. Moellering, Jr. 1996. Antimicrobial combinations, p. 330-396. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, Md.
5. Khardori, N., L. Elting, E. Wong, B. Schable, and G. P. Bodey. 1990. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev. Infect. Dis. 12:997-1003.
6. Khardori, N., A. Reuben, B. Rosenbaum, K. Rolston, and G. P. Bodey. 1990. In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents. Antimicrob. Agents Chemother. 34:1609-1610.
7. Lecso-Bornet, M., J. Pierre, D. Sarkis-Karam, S. Lubera, and E. Bergogne-Berezin. 1992. Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro. Antimicrob. Agents Chemother. 36:669-671.
8. Morrison, A. J., K. K. Hoffmann, and R. P. Wenzel. 1986. Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J. Clin. Microbiol. 24:52-55.
9. Muder, R. R., V. L. Yu, J. S. Dummer, C. Vinson, and R. M. Lumish. 1987. Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum. Arch. Intern. Med. 147:1672-1674.
10. Nagai, T. 1984. Association of Pseudomonas maltophilia with malignant lesions. J. Clin. Microbiol. 20:1003-1005.
11. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow acrobically. 4th ed. Approved standard. NCCLS publication M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
12. Pankuch, G. A., M. R. Jacobs, S. F. Rittenhouse, and P. C. Appelbaum. 1994. Susceptibilities of 123 strains of Xanthomonas maltophilia to eight β-lactams (including β-lactam-β-lactamase inhibitor combinations) and ciprofloxacin tested by five methods. Antimicrob. Agents Chemother. 38:2317-2322.
13. Poulos, C., S. O. Matsumura, B. M. Willey, D. E. Low, and A. McGeer. 1995. In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia. Antimicrob. Agents Chemother. 39:2220-2223.
14. Saino, Y., M. Inoue, and S. Mitsuhashi. 1984. Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN 12873. Antimicrob. Agents Chemother. 25:362-365.
15. Saino, Y., F. Kobayashi, M. Inoue, and S. Mitsuhashi. 1982. Purification and properties of inducible penicillin β-lactamase isolated from Pseudomonas maltophilia. Antimicrob. Agents Chemother. 22:564-570.
16. Spangler, S. K., M. A. Visalli, M. R. Jacobs, and P. C. Appelbaum. 1996. Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem. Antimicrob. Agents Chemother. 40:772-775.
17. Visalli, M. A., S. Bajaksouzian, M. R. Jacobs, and P. C. Appelbaum. 1997. Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods. Antimicrob. Agents Chemother. 41:1475-1481.
18. Zuravleff, J. J., and V. L. Yu. 1982. Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature. Rev. Infect. Dis. 4:1236-1246.